Quercetin Inhibits the Progression of Gastric Cancer Through the AKT/MAPK Signaling Pathway.

Guorong Yang, Juwu Chen, Xiangdi Yang, Jifeng Tan, Chengbin Liu, Lingyu Li, Xihua Yang, Jianfu Zhao

Abstract read

In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guorong YangResearch Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.

Juwu ChenDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.

Xiangdi YangResearch Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.

Jifeng TanResearch Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.ORCID 0009-0007-9663-3564

Chengbin LiuLuoding Hospital of Traditional Chinese Medicine, Luoding 527200, China.

Lingyu LiGuangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, College of Pharmacy, Cancer Research Institute, Jinan University, Guangzhou 510632, China.

Xihua YangDepartment of Surgical Oncology, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou 423000, China.

Jianfu ZhaoResearch Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.ORCID 0000-0001-6130-7266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epimediumgastric cancerimmune microenvironmentnetwork pharmacologyquercetinSERPINE1

Identifiers

PMID41749860

DOI10.3390/cancers18040603

PMCPMC12939258

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.